Corcept Therapeutics (CORT) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $116.26 -1.06%
EPS Growth %: +406.3%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +406.3%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $10.1 million versus the consensus estimate of $10.5 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- KB Home (KBH) Tops Q3 EPS by 16c
- Corcept names Justin Gunn president of endocrinology division
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
